I'm exactly the same. it's getting cheaper but not yet cheap enough for the risk. but I'm watching closely. if you review Glassdoor staff don't have a great opinion of the place. that is concerning.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025